Ann: 3rd Quarter Trading Update, page-17

First 17 Last

Share
Profile

Follow
Just_a_guy

3,322 Posts.

103

15/07/18

14:47

Post #: 34353039
Share

Originally posted by jg123456 ↑

VLE - no, I don't know mgmt (but I have corresponded with investors who have met the brothers and they were impressed. Personally I rarely correspond with mgmt - I mainly assess them based on track records). VLE specialises in turn-arounds - eg, a typical purchase is a loss making business, bought dirt cheap, and VLE try and turn it around. Eg, Impetus has been a stand-out success story. VLE bought it for 1.25m in 2015 - VLE's share of Impetus' tax-paid profits is now around 2m p.a (from memory) and Impetus continues to win new clients. Impetus and the surplus assets are the key VLE assets currently. VLE has significant surplus assets. In particular: 12m cash, 6m equities, and freehold property at shire ~2.6m (all IIRC). Things some people may overlook.

Yes, Shire was disappointing recently, but they've investing another 1m to target higher margin product and expect an improvement. NB. They only paid 2.5m for it. SIRA is v. small - some option value only.

No haven't looked at Ad8 - sounds like you think I should. Thanks!

Apologies to CYB holders for the off-topic posts

Expand

My apologies I should have started, or found, a uk equities thread.
To be honest I’m not sure ad8 is a buy any more as I can’t value it confidently but it is a very good growth story, with excellent management, paying its way, with a very sticky, network effects type product. I noticed tune.l was waxing on about it in one of their reports.
Thanks again for your feedback

CYB Price at posting: $5.94 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

There are more pages in this discussion • 8 more messages in this thread...

First 17 Last

Add CYB (ASX) to my watchlist

Ann: 3rd Quarter Trading Update, page-17

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Scientific conference spotlights PYC's work on blindness disease treatment

Featured News